Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 HKD | -4.03% | +10.51% | +7.04% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics